SK12593A3 - Medicament for therapy of neurological and psychical disorders, caused by an abusing of alcohols - Google Patents
Medicament for therapy of neurological and psychical disorders, caused by an abusing of alcohols Download PDFInfo
- Publication number
- SK12593A3 SK12593A3 SK12593A SK12593A SK12593A3 SK 12593 A3 SK12593 A3 SK 12593A3 SK 12593 A SK12593 A SK 12593A SK 12593 A SK12593 A SK 12593A SK 12593 A3 SK12593 A3 SK 12593A3
- Authority
- SK
- Slovakia
- Prior art keywords
- thiamine
- medicament according
- acid
- medicament
- pharmacologically
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Processing Of Solid Wastes (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19924206422 DE4206422C2 (de) | 1992-02-29 | 1992-02-29 | Arzneimittel zur Prophylaxe und Therapie von neurologischen und psychiatrischen Schäden durch Alkoholmißbrauch |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK12593A3 true SK12593A3 (en) | 1993-09-09 |
Family
ID=6452953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK12593A SK12593A3 (en) | 1992-02-29 | 1993-02-22 | Medicament for therapy of neurological and psychical disorders, caused by an abusing of alcohols |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0558960A1 (de) |
| CZ (1) | CZ22693A3 (de) |
| DE (1) | DE4206422C2 (de) |
| HU (1) | HU213095B (de) |
| PL (1) | PL171450B1 (de) |
| SK (1) | SK12593A3 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2713088B1 (fr) * | 1993-12-03 | 1996-03-22 | Bernard Aranda | Utilisation de la vitamine B1 et ses dérivés pour la préparation d'un médicament destiné au traitement des affections dont les symptômes sont attribués aux désordres d'origine vasculaire. |
| DE19629802A1 (de) * | 1996-07-24 | 1998-01-29 | Woerwag Pharma Gmbh | Arzneimittel zur Behandlung von Neuropathien |
| DE19629803A1 (de) * | 1996-07-24 | 1998-01-29 | Woerwag Pharma Gmbh | Arzneimittel zur Behandlung von Neuropathien |
| GB9906740D0 (en) | 1999-03-23 | 1999-05-19 | Kilgowan Limited | Oral combinations of hydroxocobalamin and folic acid |
| CA2433949A1 (en) * | 2000-12-14 | 2002-10-24 | Tufts University | Compositions and methods for treating an arthritic condition |
| US8142800B1 (en) * | 2001-12-18 | 2012-03-27 | Tamea Rae Sisco | Oral high potency clinical anti-craving treatment and method of use |
| US8142799B2 (en) * | 2001-12-18 | 2012-03-27 | Tamea Rae Sisco | High potency clinical anti-craving treatment and method of use |
| DE102018129085A1 (de) | 2018-11-19 | 2020-05-20 | Alexander Raßmann | Zusammensetzung zur Verbesserung des Carbonsäurestoffwechsels, Verwendung dieser und Zubereitung mit der Zusammensetzung |
-
1992
- 1992-02-29 DE DE19924206422 patent/DE4206422C2/de not_active Expired - Fee Related
-
1993
- 1993-02-10 EP EP93102029A patent/EP0558960A1/de not_active Withdrawn
- 1993-02-18 CZ CZ93226A patent/CZ22693A3/cs unknown
- 1993-02-22 SK SK12593A patent/SK12593A3/sk unknown
- 1993-02-26 HU HU9300534A patent/HU213095B/hu not_active IP Right Cessation
- 1993-02-26 PL PL29788093A patent/PL171450B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ22693A3 (en) | 1993-12-15 |
| HUT64230A (en) | 1993-12-28 |
| EP0558960A1 (de) | 1993-09-08 |
| PL297880A1 (en) | 1993-12-13 |
| DE4206422C2 (de) | 1996-07-11 |
| HU213095B (en) | 1997-02-28 |
| DE4206422A1 (de) | 1993-09-02 |
| PL171450B1 (pl) | 1997-04-30 |
| HU9300534D0 (en) | 1993-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Douglas et al. | Metabolic effects of recombinant human growth hormone: isotopic studies in the postabsorptive state and during total parenteral nutrition | |
| Krecic‐Shepard et al. | Gender‐specific effects on verapamil pharmacokinetics and pharmacodynamics in humans | |
| EP0898965B9 (de) | Verwendung von 5-methyl-(6S)-tetrahydrofolsäure zur Vorbeugung von Neuralrohrdefekten | |
| Bell et al. | S‐adenosylmethionine blood levels in major depression: changes with drug treatment | |
| NELSON et al. | Phenobarbital pharmacokinetics and bioavailability in adults | |
| EP1603580B1 (de) | Zusammensetzung zur verabreichung von eisen für die behandlung des unruhigen beinsyndroms | |
| JP2004501964A (ja) | 新規な葉酸代謝拮抗薬の組み合わせ療法 | |
| CHALHUB et al. | Phenytoin‐induced dystonia and choreoathetosis in two retarded epileptic children | |
| SK12593A3 (en) | Medicament for therapy of neurological and psychical disorders, caused by an abusing of alcohols | |
| Yildizdas et al. | Pulmonary hypertension, heart failure and neutropenia due to diazoxide therapy | |
| Georges et al. | Metabolic effects of propranolol in thyrotoxicosis. I. Nitrogen, calcium, and hydroxyproline | |
| Wood et al. | Drug-induced psychosis and depression in the elderly | |
| US20050215625A9 (en) | Combination therapy for anticoagulation | |
| McDonald et al. | Parenteral methotrexate in psoriasis: A report on the efficacy and toxicity of long-term intermittent treatment | |
| Gahm et al. | Chronic cerebellar stimulation for cerebral palsy: a double‐blind study | |
| JP2023500360A (ja) | Ｎ－アセチルシステインの鼻腔内投与のための用量、製剤、およびデバイスを較正および選択するための磁気共鳴分光法の使用 | |
| Kirkemo et al. | Serum vitamin level maintenance in cancer patients on total parenteral nutrition | |
| Marcus et al. | Digoxin bioavailability: Formulations and rates of infusions | |
| Knopp et al. | Diphenylhydantoin and an insulin-secreting islet adenoma | |
| US20020010148A1 (en) | Oral combinations of hydroxocobalamin and folic acid | |
| Garrettson | Pharmacology of anticonvulsants | |
| Giffard et al. | Secobarbital Attenuates Excitotoxicity but Potentiates Oxygen—Glucose Deprivation Neuronal Injury in Cortical Cell Culture | |
| Leppik | Phenytoin | |
| EP0383680B1 (de) | Pentamidinlösungen | |
| Clancy et al. | Neonatal theophylline neurotoxicity |